English NHS Failing To Meet Targets For Availability Of NICE-Approved Cancer Drugs

 
• By Leela Barham

England’s National Health Service has yet to meet targets for speedy availability of anticancer drugs that have gone through an early access scheme and then been green-lit by NICE.

Pink Sheet analysis shows that availability targets for cancer drugs approved under the UK’s Early Access to Medicines Scheme are routinely missed. (Shutterstock)

More from Europe

More from Market Access